Interventions for treating hyperemesis gravidarum: a network meta-analysis of randomized clinical trials

The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Kannan Sridharan, Gowri Sivaramakrishnan

Abstract

Several interventions were explored in clinical trials for treating hyperemesis gravidarum (HG). The present study is a network meta-analysis of such interventions. Electronic databases were searched for appropriate randomized clinical trials comparing interventions for treatment of patients with HG. Control of HG symptoms was the primary outcome and emetic episodes, hospital stay, nausea scores, patients requiring rescue antiemetics, hospital readmission, adverse events, and adverse pregnancy outcomes were the secondary outcome measures. Random-effects model was used and odds ratio (OR) [95% confidence interval (CI)] was the effect estimate for categorical outcomes and weighted mean difference (WMD) [95% confidence interval] for numerical outcomes. Twenty studies were included in the systematic review and 18 in the meta-analysis. Acupuncture (OR: 18.9; 95% CI: 2.1, 168), acupressure (OR: 26.7; 95% CI: 2.5, 283.1) and methylprednisolone (OR: 6.7; 95% CI: 1.1, 38.8) were associated with better control of HG symptoms than standard of care. Acupressure decreases the requirement of rescue antiemetics (OR: 0.06; 95% CI: 0.01, 0.44); ondansetron with reduced hospital stay (WMD: -0.2; 95% CI: -0.31, -0.01) and diazepam with reduced ri...Continue Reading

References

Jan 4, 1991·European Journal of Obstetrics, Gynecology, and Reproductive Biology·W Fischer-RasmussenU Asping
May 1, 1996·American Journal of Obstetrics and Gynecology·C A SullivanJ C Morrison
Oct 28, 1998·American Journal of Obstetrics and Gynecology·H R SafariT M Goodwin
Oct 12, 2000·Journal of Pain and Symptom Management·C P CarlssonC Navander
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Mar 5, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Saeideh ZiaeiSoghrate Faghihzadeh
Mar 9, 2004·Forschende Komplementärmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine·D HabekM Bobić-Vuković
Sep 10, 2005·American Journal of Obstetrics and Gynecology·Jennifer L Bailit
Mar 9, 2006·American Journal of Obstetrics and Gynecology·Alexander HeazellIan Etherington
Sep 8, 2006·Critical Care Medicine·Rasha S BondokAhmed M Abd Elmaksoud
Dec 7, 2007·Journal of Perinatology : Official Journal of the California Perinatal Association·B PoursharifT M Goodwin
Dec 17, 2008·Gynecologic and Obstetric Investigation·Peng Chiong TanSiti Zawiah Omar
Nov 28, 2009·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Neda EbrahimiGideon Koren
Apr 23, 2010·Obstetrics and Gynecology·Peng Chiong TanSiti Zawiah Omar
May 9, 2014·Obstetrics and Gynecology·Mohamed Norazam AbasSiti Zawiah Omar
Dec 24, 2014·The Journal of Perinatal & Neonatal Nursing·Melody J Castillo, Julia C Phillippi
Sep 18, 2015·BMJ : British Medical Journal·Philip Sedgwick, Louise Marston
Nov 9, 2016·Journal of Obstetrics and Gynaecology of India·Ashraf AleyasinMohammadreza Javadi
Jun 16, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Rupsa C BoeligVincenzo Berghella
Jun 24, 2017·Pharmacology·Viktoriya LondonOvadia Abulafia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.